Evidence for antibody as a protective correlate for COVID-19 vaccines

A correlate of protection (CoP) is urgently needed to expedite development of additional COVID-19 vaccines to meet unprecedented global demand. To assess whether antibody titers may reasonably predict efficacy and serve as the basis of a CoP, we evaluated the relationship between efficacy and in vit...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Vaccine
Autori principali: Earle, Kristen A., Ambrosino, Donna M., Fiore-Gartland, Andrew, Goldblatt, David, Gilbert, Peter B., Siber, George R., Dull, Peter, Plotkin, Stanley A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier Science 2021
Soggetti:
Short Communication
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8142841/
https://ncbi.nlm.nih.gov/pubmed/34210573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2021.05.063
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi